Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
1983 • 7,404 citations
Matrix Metalloproteinases: A Review
1993 • 2,998 citations
The clinical course of neuromyelitis optica (Devic’s syndrome)
1999 • 1,772 citations
Quantitative Zymography: Detection of Picogram Quantities of Gelatinases
1994 • 866 citations
Matrix metalloproteinases and diseases of the CNS
1998 • 646 citations
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.
1985 • 625 citations
Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.
1986 • 531 citations
T cell gelatinases mediate basement membrane transmigration in vitro.
1995 • 507 citations
Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine
1998 • 382 citations
Matrix Metalloproteinases in Cerebrovascular Disease
1998 • 353 citations
Devic's neuromyelitis optica: A clinicopathological study of 8 patients
1993 • 339 citations
Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
1994 • 338 citations
Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
1992 • 286 citations
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
1992 • 282 citations
Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis
1996 • 278 citations
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke
1997 • 265 citations
Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window
1995 • 260 citations
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
1999 • 232 citations
Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and Neurons
1996 • 211 citations
Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
2000 • 190 citations
Quantitative Reverse Zymography: Analysis of Picogram Amounts of Metalloproteinase Inhibitors Using Gelatinase A and B Reverse Zymograms
1997 • 167 citations
Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
1995 • 146 citations
Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
1999 • 127 citations
Proteolysis and myelin breakdown: a review of recent histochemical and biochemical studies
1969 • 101 citations
Protease production by cultured microglia: Substrate gel analysis and immobilized matrix degradation
1993 • 83 citations
Evaluation of gelatinases and IL‐6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases
1994 • 74 citations
Immunological effects of oral high‐dose methylprednisolone in acute optic neuritis and multiple sclerosis
2000 • 63 citations
ESTERASE, PEPTIDASE AND PROTEINASE ACTIVITIES OF HUMAN CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS
1968 • 51 citations
Devic's neuromyelitis optica: long-term follow-up and serial CSF findings in two cases
1990 • 24 citations
Cited By (0)
No citing papers found in database